Synektik

Synektik Cash Flow per Share

The Operating Cash Flow per Share of Synektik (SNT.WA) as of Oct 31, 2026 is 9.11 PLN. In the previous year, Operating Cash Flow per Share was 10.51 PLN — a change of -13.26% (lower).

Cash Flow per Share

9.11PLN

YoY

-13.26%

Last updated:

Operating Cash Flow per Share of Synektik is 2025 9.11 PLN. Operating Cash Flow per Share of Synektik was 2024 10.51 PLN. It decreases by -13.26% lower compared to the previous year.

The Synektik Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
0.61 PLN
Jan 1, 2019
1.59 PLN
Jan 1, 2020
1.63 PLN
Jan 1, 2021
2.55 PLN
Jan 1, 2022
-0.73 PLN
Jan 1, 2023
11.08 PLN
Jan 1, 2024
10.51 PLN
Jan 1, 2025
9.11 PLN
The Synektik Cash Flow per Share history
YEARCash Flow per ShareYoY
9.11PLN-13.26%
10.51PLN-5.17%
11.08PLN-1,628.09%
-0.73PLN-128.48%
2.55PLN+55.88%
1.63PLN+2.81%
1.59PLN+159.30%
0.61PLN-64.15%
1.71PLN-280.75%
-0.95PLN-240.87%
0.67PLN-52.16%
1.40PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Operating Cash Flow per Share of Synektik is 9.11 PLN in 2025.

Operating Cash Flow per Share of Synektik changed from 10.51 PLN to 9.11 PLN, representing a -13.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Synektik since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Synektik

All Key Metrics — Synektik